Jefferies Initiates Coverage On Artivion with Buy Rating, Announces Price Target of $31

10/20/2026
Impact: 80
Healthcare

Jefferies analyst Michael Sarcone has initiated coverage on Artivion (NYSE: AORT) with a Buy rating. The firm has set a price target of $31 for the company's stock.

AI summary, not financial advice

Share: